---
title: "Inhibrx (INBX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INBX.US/norm.md"
symbol: "INBX.US"
name: "Inhibrx"
parent: "https://longbridge.com/zh-CN/quote/INBX.US.md"
datetime: "2026-05-21T21:41:46.816Z"
locales:
  - [en](https://longbridge.com/en/quote/INBX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INBX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INBX.US/norm.md)
---

# Inhibrx (INBX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 |
| ROE | 2051.28% | -586.02% | -267.63% | -140.63% | -151.95% |
| 营业收入 | - | 0.0000 | - | 1.30M | - |
| 净利润 | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M |
| 营业利润 | -30.93M | -30.92M | -33.81M | -27.39M | -42.90M |
| 毛利率 | - | - | - | -1612.85% | - |
| 净利率 | - | - | - | -2204.15% | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 183.97M | 146.48M | 177.47M | 212.12M | 242.64M |
| 权益乘数 | -8.75 | 18.33 | 4.82 | 3.09 | 2.57 |
| 每股净资产 | -1.44 | 0.5483 | 2.54 | 4.74 | 6.52 |
| 资产周转率 | 0.0061 | 0.0079 | 0.0070 | 0.0060 | 0.0015 |
| 现金及短投 | 161.66M | 124.22M | 153.09M | 186.57M | 216.52M |
| 存货与应收 | 1.56M | 1.88M | 2.25M | 2.48M | 1.89M |
| 长期投资 | 8.25M | 9.27M | 10.31M | 11.35M | 12.45M |
| 净债务 | 19.24M | -17.21M | -46.18M | -79.78M | -109.99M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -38.03M | -30.12M | -33.82M | -29.95M | -35.90M |
| 投资现金流 | - | 0.0000 | -7000.00 | 0.0000 | -21000.00 |
| 融资现金流 | 75.46M | 1.25M | 352000.00 | 0.0000 | 99.84M |
| 自由现金流 | -24.58M | -18.56M | -21.36M | -19.11M | -20.24M |
| 现金流充裕率 | - | - | -338240.00% | - | -170928.57% |
| 举债与偿债 | 74.99M | 0.0000 | 0.0000 | 0.0000 | 99.97M |
| 资本支出 | - | 0.0000 | -10000.00 | 0.0000 | -21000.00 |